Adventa Berhad (KLSE:ADVENTA) Is Looking To Continue Growing Its Returns On Capital

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. With that in mind, we've noticed some promising trends at Adventa Berhad (KLSE:ADVENTA) so let's look a bit deeper.

Advertisement

Return On Capital Employed (ROCE): What Is It?

For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. To calculate this metric for Adventa Berhad, this is the formula:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.15 = RM10m ÷ (RM85m - RM16m) (Based on the trailing twelve months to June 2022).

Thus, Adventa Berhad has an ROCE of 15%. In isolation, that's a pretty standard return but against the Medical Equipment industry average of 20%, it's not as good.

See our latest analysis for Adventa Berhad

roce
KLSE:ADVENTA Return on Capital Employed October 25th 2022

Historical performance is a great place to start when researching a stock so above you can see the gauge for Adventa Berhad's ROCE against it's prior returns. If you want to delve into the historical earnings, revenue and cash flow of Adventa Berhad, check out these free graphs here.

How Are Returns Trending?

Adventa Berhad has not disappointed in regards to ROCE growth. We found that the returns on capital employed over the last five years have risen by 576%. That's not bad because this tells for every dollar invested (capital employed), the company is increasing the amount earned from that dollar. Interestingly, the business may be becoming more efficient because it's applying 37% less capital than it was five years ago. If this trend continues, the business might be getting more efficient but it's shrinking in terms of total assets.

The Key Takeaway

From what we've seen above, Adventa Berhad has managed to increase it's returns on capital all the while reducing it's capital base. Investors may not be impressed by the favorable underlying trends yet because over the last five years the stock has only returned 7.6% to shareholders. So with that in mind, we think the stock deserves further research.

Adventa Berhad does have some risks though, and we've spotted 4 warning signs for Adventa Berhad that you might be interested in.

For those who like to invest in solid companies, check out this free list of companies with solid balance sheets and high returns on equity.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About KLSE:ADVENTA

Adventa Berhad

An investment holding company, engages in the supply of healthcare and related products and services to hospitals, healthcare centers, and pharmacies in Malaysia, Sri Lanka, and internationally.

Flawless balance sheet with low risk.

Advertisement

Weekly Picks

CE
Ceazar
GOAI logo
Ceazar on Eva Live ·

This small cap is building the AI workforce of the future

Fair Value:US$7.4351.3% undervalued
84 users have followed this narrative
0 users have commented on this narrative
17 users have liked this narrative
TR
tripledub
LULU logo
tripledub on lululemon athletica ·

Lululemon Got Boring Right About the Time It Got Cheap. That's Usually the Point

Fair Value:US$22042.2% undervalued
26 users have followed this narrative
6 users have commented on this narrative
29 users have liked this narrative
WO
woodworthfund
KHC logo
woodworthfund on Kraft Heinz ·

Kraft Heinz (KHC): Less Drama, More Ketchup

Fair Value:US$3532.0% undervalued
9 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
CA
Canderous
TAL logo
Canderous on PetroTal ·

Beyond 2026, Beyond a Double

Fair Value:CA$1.8166.9% undervalued
30 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative

Updated Narratives

RO
RockeTeller
SCMI logo
RockeTeller on Selkirk Copper Mines ·

Selkirk Copper, Ex-Teck + 87% Hit Rate Maybe The Highest-Conviction Copper Restart in Canada Now

Fair Value:CA$21.7491.3% undervalued
2 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
JA
Janpeo
NBI logo
Janpeo on NBI Bearings Europe ·

NBI Bearings Europe Revenue to Surge with 7.38% Growth

Fair Value:€6.958.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7444.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8590.4% undervalued
114 users have followed this narrative
2 users have commented on this narrative
31 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$268.6119.8% undervalued
1193 users have followed this narrative
7 users have commented on this narrative
34 users have liked this narrative
TR
tripledub
LULU logo
tripledub on lululemon athletica ·

Lululemon Got Boring Right About the Time It Got Cheap. That's Usually the Point

Fair Value:US$22042.2% undervalued
26 users have followed this narrative
6 users have commented on this narrative
29 users have liked this narrative